How Does NGS Compare with Other Approaches to Measure MRD?

Track: BMT Tandem "Scientific" Meeting
Saturday, February 14, 2015, 7:15 AM-8:15 AM
Seaport A-E (Manchester Grand Hyatt)
Frederick R. Appelbaum, MD , Fred Hutchinson Cancer Research Center, Seattle, WA
Audio File Recorded Presentation
Disclosures:
F. R. Appelbaum, Adaptive Biotechnologies, Consultant: Consultancy
Amgen, Consultant: Honoraria
Celator, Consultant: Honoraria
Igenica, Consultant: Honoraria
See more of: BMT Tandem Breakfast Symposium: Measuring Minimal Residual Disease: The Potential and Pitfalls of Next-Generation Sequencing
See more of: BMT Tandem "Scientific" Meeting
<< Previous Presentation | Next Presentation >>